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peptide observed by mass spectrometry region targeted by siRNA pool Figure S1 . RuvBL1 and RuvBL2 are highly conserved. Protein sequence alignments generated with ClustalW demonstrate strong conservation of vertebrate RuvBL1 (A) and human and mouse RuvBL2 (B). Gallus gallus RuvBL2 has not been detected in the published chicken proteome owing to incomplete annotation. Red bars indicate regions targeted with siRNAs in the Dharmacon ON-TARGET SMARTpool. Black bars lines indicate peptide regions identified by mass spectrometry of the purified FA core complex. In the case of RuvBL2 mass spectrometry, peptides from the Bos taurus and Xenopus laevis orthologues were detected. The alignment has been coloured by ClustalX notation. Each residue is coloured based on the occurrence of particular residues at the specified position:
Cyan (H, Y) and Yellow (P). Figure 2B . Each point represents the mean of triplicate samples and the error bars are the SD. (B,C) U2OS cells were stably transfected with empty vector or plasmid encoding siRNA-resistant FLAG-RuvBL1. WCEs from three independent FLAG-RuvBL1 clones, vector control and untransfected cells (U2OS) were analysed by Western blotting with indicated antibodies (B). Stable overexpression of FLAG-RuvBL1 caused partial down-regulation of the endogenous RuvBL1 protein. It was not possible to obtain cell lines stably expressing a catalytic-dead mutant of RuvBL1 (D302N) suggesting that this protein may function in a dominant negative manner. Stable cell lines expressing siRNA-insensitive FLAG-RuvBL1 rescue MMC sensitivity after depletion of endogenous RuvBL1 (C). MMC sensitivity was determined after treatment with a non-targeting pool of siRNA (NTP; solid lines) or with a siRNA targeting the 3ʹ-UTR of endogenous RuvBL1 not encoded in the overexpression construct (Q11; dotted lines). Both U2OS cells (black) and a cell line with a stably integrated empty vector (blue) were hypersensitive to MMC after RuvBL1 knockdown. However, three independent clones expressing FLAG-RuvBL1 (green, pink, orange) showed partial to complete rescue of sensitivity. Each point represents the mean of triplicate samples and the error bars are the SD. Figure 3B performed with single siRNAs. Cells were treated with indicated siRNAs and exposed to MMC or left untreated. WCEs were blotted with the indicated antibodies. (C) FA defects after RuvBL1 depletion are rescued by wild-type but not ATPase deficient RuvBL1: U2OS WCEs were blotted with indicated antibodies after simultaneous depletion of RuvBL1 with a siRNA targeting the 3ʹ-UTR (Q11) and transient overexpression of a cDNA encoding FLAG-RuvBL1 (insensitive to siRNA) or a vector control. FLAG-RuvBL1 expression rescued protein levels of ATR, mTOR, RuvBL2 and FANCA, and monoubiquitination of FANCI. Overexpression of an empty vector or catalytic-dead mutant (D302N) were not able to functionally rescue RuvBL1 depletion. The D302N mutant partially rescued the level of RuvBL2 indicating that the catalytic mutant likely retains the ability to form a higher order, albeit inactive, heteromeric assembly with RuvBL2. Figure S5 . Subcellular localisation of the Fanconi Anaemia core complex is not impaired in RuvBL1-RuvBL2-depleted cells. U2OS cells were treated with either a non-targeting siRNA pool (NTP) or single siRNAs targeting both RuvBL1 and RuvBL2 and exposed to 1 µM MMC or left untreated. Cells were fractionated into (A) cytoplasmic (cyt) and nuclear (nuc) compartments or (B) a chromatin-enriched fraction and subjected to blotting with indicated antibodies. Although the abundance of the FA core complex is reduced after RuvBL1-RuvBL2 depletion, it is localised normally relative to cells treated with the control siRNA. Weak monoubiquitination of FANCI is clearly observed on chromatin, where the monoubiquitinated species are heavily enriched in vivo, suggesting that RuvBL1-RuvBL2 depletion severely reduces, but does not fully abrogate, this modification. The presence of residual RuvBL1 and RuvBL2 in the same fraction, likely a consequence of incomplete siRNA-mediated suppression, could also account for residual monoubiquitinated substrates. β-tubulin serves as a cytoplasmic loading control; laminB1 serves as a nuclear/nuclear matrix loading control; and histone H3 serves as a chromatin loading control. It is not clear whether the upper band in the FANCA panel is a modified form of FANCA or a cross-reacting protein. The formation of nuclear FANCE foci (which occur independent of MMC-induced damage) is intact. Although FANCD2 and FANCI are not efficiently monoubiquitinated after RuvBL1-RuvBL2 depletion, they can still localise to chromatin and are able to form nuclear foci, albeit in a reduced capacity. DAPI staining of nuclei is in blue and FANCE, FANCD2 and FANCI are in magenta. Figure S9 . Regulation of the abundance of the FA core complex by RuvBL1-RuvBL2 is not influenced by translational inhibition, HSP90 inhibition or proteasome-mediated degradation. U2OS cells were treated with either a non-targeting siRNA pool (NTP) or single siRNAs targeting both RuvBL1 and RuvBL2 (Ruv) and exposed to the indicated doses of translation inhibitor cyclohexamide (CHX), HSP90 inhibitor 17-AAG or proteasome inhibitor MG132 for indicated times. WCEs were analysed by Western blotting with indicated antibodies. Significant changes in FANCA and FANCE protein levels were not observed in control samples after CHX treatment. HSP90 inhibition specifically caused depletion of FANCA, as previously reported (90) but not FANCE. The effect of 17-AAG on FANCA abundance appears additive and mechanistically distinct from RuvBL1-RuvBL2-mediated reduction. MG132 is able to prevent 17-AAGinduced degradation of FANCA (90) but critically does not inhibit RuvBL1-RuvBL2-mediated loss of FANCA and FANCE. FANCA and FANCE levels could not be rescued by proteasomal inhibition with MG132. These effects were also observed with the PIKKs ATR and mTOR whose abundance is also regulated by RuvBL1-RuvBL2 (31). Flox/Flox mice were crossed with mice carrying the CreERT2 recombinase under the control of the Lmo2 promoter which, upon tamoxifen treatment, should lead to deletion of the third exon in the Ruvbl1 locus (Ruvbl1 tm1d(EUCOMM)Wtsi allele) in haematopoietic stem cells. (B) Targeted integration of the targeting construct by homologous recombination was confirmed by long range PCR. Oligonucleotide pairs were used in which one oligo binds within the targeting construct whilst the other binds externally to the homology arms. Targeting of the 5ʹ arm was confirmed using oligos GF4 and LAR3, whilst the 3ʹ arm was confirmed by RAF5 and GR3. Both PCR reactions generated products of the predicted size of 6483 bp and 6833 bp, respectively. (C) Following blastocyst injection of the targeted ES cells, germline transmission was achieved. The progeny were genotyped using a PCR strategy in which the wild type allele was amplified with oligos Ruv1F1 and Ruv1R1, generating a 589 bp product. The targeted allele Ruvbl1 tm1a(EUCOMM)Wtsi was amplified with oligos Ruv1F1 and En2A generating a 436 bp product. The same PCR strategy was able to detect recombination between FRT sites and to genotype mice carrying the Ruvbl1
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Flox allele (736 bp).
